Annual CFI
-$80.08 M
-$150.80 M-213.25%
31 December 2023
Summary:
MacroGenics annual cash flow from investing activities is currently -$80.08 million, with the most recent change of -$150.80 million (-213.25%) on 31 December 2023. During the last 3 years, it has fallen by -$72.30 million (-928.70%). MGNX annual CFI is now -202.84% below its all-time high of $77.88 million, reached on 31 December 2017.MGNX Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
$35.60 M
-$11.84 M-24.96%
30 September 2024
Summary:
MacroGenics quarterly cash flow from investing activities is currently $35.60 million, with the most recent change of -$11.84 million (-24.96%) on 30 September 2024. Over the past year, it has increased by +$69.12 million (+206.19%). MGNX quarterly CFI is now -51.32% below its all-time high of $73.13 million, reached on 30 June 2017.MGNX Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
$146.65 M
+$69.12 M+89.16%
30 September 2024
Summary:
MacroGenics TTM cash flow from investing activities is currently $146.65 million, with the most recent change of +$69.12 million (+89.16%) on 30 September 2024. Over the past year, it has increased by +$271.35 million (+217.61%). MGNX TTM CFI is now at all-time high.MGNX TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MGNX Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -213.3% | +206.2% | +217.6% |
| 3 y3 years | -928.7% | +1460.3% | +474.8% |
| 5 y5 years | -241.4% | +658.7% | +449.9% |
MGNX Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -213.3% | at low | -50.5% | +131.4% | at high | +217.6% |
| 5 y | 5 years | -213.3% | at low | -50.5% | +131.4% | at high | +217.6% |
| alltime | all time | -202.8% | +47.4% | -51.3% | +124.4% | at high | +167.3% |
MacroGenics Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $35.60 M(-25.0%) | $146.65 M(+89.2%) |
| June 2024 | - | $47.44 M(+91.3%) | $77.53 M(-193.0%) |
| Mar 2024 | - | $24.79 M(-36.1%) | -$83.39 M(+4.1%) |
| Dec 2023 | -$80.08 M(-213.2%) | $38.82 M(-215.8%) | -$80.08 M(-35.8%) |
| Sept 2023 | - | -$33.52 M(-70.5%) | -$124.69 M(+548.7%) |
| June 2023 | - | -$113.48 M(-503.9%) | -$19.22 M(-116.4%) |
| Mar 2023 | - | $28.09 M(-585.4%) | $117.29 M(+65.9%) |
| Dec 2022 | $70.72 M(-293.2%) | -$5.79 M(-108.0%) | $70.72 M(+12.3%) |
| Sept 2022 | - | $71.95 M(+212.3%) | $62.95 M(-642.1%) |
| June 2022 | - | $23.04 M(-224.7%) | -$11.61 M(-44.3%) |
| Mar 2022 | - | -$18.48 M(+36.4%) | -$20.83 M(-43.1%) |
| Dec 2021 | -$36.61 M(+370.3%) | -$13.55 M(+417.9%) | -$36.61 M(-6.4%) |
| Sept 2021 | - | -$2.62 M(-118.9%) | -$39.13 M(-51.0%) |
| June 2021 | - | $13.82 M(-140.3%) | -$79.80 M(+51.7%) |
| Mar 2021 | - | -$34.26 M(+113.1%) | -$52.61 M(+575.7%) |
| Dec 2020 | -$7.79 M(-90.2%) | -$16.07 M(-62.9%) | -$7.79 M(-148.9%) |
| Sept 2020 | - | -$43.28 M(-205.5%) | $15.92 M(-69.9%) |
| June 2020 | - | $41.01 M(+288.2%) | $52.83 M(+3011.0%) |
| Mar 2020 | - | $10.56 M(+38.5%) | $1.70 M(-102.1%) |
| Dec 2019 | -$79.36 M(-240.1%) | $7.63 M(-219.7%) | -$79.36 M(+89.4%) |
| Sept 2019 | - | -$6.37 M(-37.0%) | -$41.91 M(+17.9%) |
| June 2019 | - | -$10.12 M(-85.6%) | -$35.54 M(+6.9%) |
| Mar 2019 | - | -$70.49 M(-256.4%) | -$33.23 M(-158.7%) |
| Dec 2018 | $56.64 M | $45.07 M(<-9900.0%) | $56.64 M(+180.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2018 | - | -$6000.00(-99.9%) | $20.21 M(-18.1%) |
| June 2018 | - | -$7.81 M(-140.3%) | $24.68 M(-76.6%) |
| Mar 2018 | - | $19.39 M(+124.4%) | $105.62 M(+35.6%) |
| Dec 2017 | $77.88 M(-210.9%) | $8.64 M(+93.5%) | $77.88 M(+9.3%) |
| Sept 2017 | - | $4.46 M(-93.9%) | $71.27 M(+12.0%) |
| June 2017 | - | $73.13 M(-975.1%) | $63.64 M(-196.3%) |
| Mar 2017 | - | -$8.36 M(-510.9%) | -$66.07 M(-5.9%) |
| Dec 2016 | -$70.25 M(-53.8%) | $2.03 M(-164.3%) | -$70.25 M(-67.8%) |
| Sept 2016 | - | -$3.16 M(-94.4%) | -$217.97 M(+0.3%) |
| June 2016 | - | -$56.59 M(+351.5%) | -$217.42 M(+32.9%) |
| Mar 2016 | - | -$12.53 M(-91.4%) | -$163.64 M(+7.6%) |
| Dec 2015 | -$152.11 M(+4158.3%) | -$145.69 M(+5486.3%) | -$152.11 M(+1783.7%) |
| Sept 2015 | - | -$2.61 M(-7.3%) | -$8.07 M(+31.5%) |
| June 2015 | - | -$2.81 M(+182.0%) | -$6.14 M(+48.9%) |
| Mar 2015 | - | -$997.00 K(-39.9%) | -$4.12 M(+15.4%) |
| Dec 2014 | -$3.57 M(+20.6%) | -$1.66 M(+146.7%) | -$3.57 M(+25.9%) |
| Sept 2014 | - | -$672.00 K(-15.5%) | -$2.84 M(-14.7%) |
| June 2014 | - | -$795.00 K(+77.9%) | -$3.33 M(+11.5%) |
| Mar 2014 | - | -$447.00 K(-51.6%) | -$2.98 M(+0.7%) |
| Dec 2013 | -$2.96 M(+215.0%) | -$924.00 K(-20.4%) | -$2.96 M(+45.4%) |
| Sept 2013 | - | -$1.16 M(+157.5%) | -$2.04 M(+132.5%) |
| June 2013 | - | -$450.90 K(+6.1%) | -$876.00 K(+106.1%) |
| Mar 2013 | - | -$425.10 K | -$425.10 K |
| Dec 2012 | -$940.00 K(+87.9%) | - | - |
| Dec 2011 | -$500.20 K | - | - |
FAQ
- What is MacroGenics annual cash flow from investing activities?
- What is the all time high annual CFI for MacroGenics?
- What is MacroGenics annual CFI year-on-year change?
- What is MacroGenics quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for MacroGenics?
- What is MacroGenics quarterly CFI year-on-year change?
- What is MacroGenics TTM cash flow from investing activities?
- What is the all time high TTM CFI for MacroGenics?
- What is MacroGenics TTM CFI year-on-year change?
What is MacroGenics annual cash flow from investing activities?
The current annual CFI of MGNX is -$80.08 M
What is the all time high annual CFI for MacroGenics?
MacroGenics all-time high annual cash flow from investing activities is $77.88 M
What is MacroGenics annual CFI year-on-year change?
Over the past year, MGNX annual cash flow from investing activities has changed by -$150.80 M (-213.25%)
What is MacroGenics quarterly cash flow from investing activities?
The current quarterly CFI of MGNX is $35.60 M
What is the all time high quarterly CFI for MacroGenics?
MacroGenics all-time high quarterly cash flow from investing activities is $73.13 M
What is MacroGenics quarterly CFI year-on-year change?
Over the past year, MGNX quarterly cash flow from investing activities has changed by +$69.12 M (+206.19%)
What is MacroGenics TTM cash flow from investing activities?
The current TTM CFI of MGNX is $146.65 M
What is the all time high TTM CFI for MacroGenics?
MacroGenics all-time high TTM cash flow from investing activities is $146.65 M
What is MacroGenics TTM CFI year-on-year change?
Over the past year, MGNX TTM cash flow from investing activities has changed by +$271.35 M (+217.61%)